Analysis of different risk factors of hospitalized COVID-19 patients from North-Eastern Bangladesh
暂无分享,去创建一个
Md. Faruque Miah | Mohammad Golam Rob Mahmud | Jilwatun Noor | Md. Toasin Hossain Aunkor | F. Rahman | Darimi Hasin
[1] A. Sufian,et al. Impact of COVID-19 pandemic on tourism geographies of Bangladesh: study on Sylhet region , 2022, GeoJournal.
[2] Mohammed Hasan Mukhtar,et al. Elucidating the Correlation of D-Dimer Levels with COVID-19 Severity: A Scoping Review , 2022, Anemia.
[3] Z. Shankayi,et al. Cardiomegaly found in hospitalized patients with novel coronavirus disease (COVID-19) , 2022, new microbes and new infections.
[4] Minghuan Wang,et al. Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study , 2022, Frontiers in Medicine.
[5] L. Sukrisman,et al. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital , 2021, The Journal of international medical research.
[6] M. Idzko,et al. Impact of persistent D-dimer elevation following recovery from COVID-19 , 2021, PloS one.
[7] M. Billah,et al. Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience , 2021, Journal of Infection and Public Health.
[8] A. Seidler,et al. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis , 2021, BMJ Global Health.
[9] A. Aminuddin,et al. COVID-19 and Hypertension: The What, the Why, and the How , 2021, Frontiers in Physiology.
[10] A. Mannan,et al. A multi-centre, cross-sectional study on coronavirus disease 2019 in Bangladesh: clinical epidemiology and short-term outcomes in recovered individuals , 2021, New Microbes and New Infections.
[11] M. Billah,et al. An online observational study assessing clinical characteristics and impacts of the COVID-19 pandemic on mental health: a perspective study from Bangladesh , 2021, Journal of Public Health.
[12] M. Nasir,et al. Survival and Biomarkers of COVID-19 Patients Treated with Remdesivir and Favipiravir in ICU during the Peak of Pandemic: A Single Center Study in Bangladesh , 2021 .
[13] Zhenyu Li,et al. The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019 , 2020, EMBO molecular medicine.
[14] M. Rahman,et al. COVID-19 pandemic, socioeconomic crisis and human stress in resource-limited settings: A case from Bangladesh , 2020, Heliyon.
[15] Ritesh Gupta,et al. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[16] N. Bhardwaj,et al. C-reactive protein as a prognostic marker of Plasmodiumfalciparum malaria severity , 2019, Journal of vector borne diseases.
[17] A. Holland,et al. Recovery Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease – A Review , 2019, COPD.
[18] J. Carcillo,et al. Hyperferritinemia and inflammation , 2017, International immunology.
[19] C. Billington,et al. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet , 2017, Physiology & Behavior.
[20] S. Takach Lapner,et al. Review of D‐dimer testing: Good, Bad, and Ugly , 2017, International journal of laboratory hematology.
[21] Y. Lim,et al. Interaction of Vitamin D and Smoking on Inflammatory Markers in the Urban Elderly , 2015, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[22] J. Foote,et al. Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers , 2015, International journal of inflammation.
[23] L. Pączek,et al. Inflammatory Markers Change with Age, but do not Fall Beyond Reported Normal Ranges , 2015, Archivum Immunologiae et Therapiae Experimentalis.
[24] Jinyan Shao,et al. Gender Differences in the Symptoms, Signs, Disease History, Lesion Position and Pathophysiology in Patients with Pulmonary Embolism , 2015, PloS one.
[25] G. Yan,et al. Serum CRP and urinary trypsin inhibitor implicate postoperative cognitive dysfunction especially in elderly patients , 2015, The International journal of neuroscience.
[26] G. Sesti,et al. Role of C Reactive Protein (CRP) in Leptin Resistance , 2014, Current pharmaceutical design.
[27] L. Bathum,et al. Age- and sex-dependent reference intervals for D-dimer: evidence for a marked increase by age. , 2013, Thrombosis research.
[28] Y. Shoenfeld,et al. The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome , 2013, BMC Medicine.
[29] E. Arellano,et al. C-Reactive Protein and Serum Amyloid A Overexpression in Lung Tissues of Chronic Obstructive Pulmonary Disease Patients: A Case-Control Study , 2013, International journal of medical sciences.
[30] V. Master,et al. Systematic Review of the Evidence of a Relationship Between Chronic Psychosocial Stress and C-Reactive Protein , 2013, Molecular Diagnosis & Therapy.
[31] B. Cosmi,et al. Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence , 2013, Internal and Emergency Medicine.
[32] S. Berliner,et al. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection , 2010, BMC infectious diseases.
[33] W. Koenig,et al. CRP in Cardiovascular Disease , 2009, Herz.
[34] V. Salomaa,et al. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. , 2005, European heart journal.
[35] A. Szalai. C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures , 2004, Clinical & developmental immunology.
[36] M. Pepys. C-reactive protein and the acute phase response , 1982, Nature.